Active Pharmaceutical Ingredients Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Active Pharmaceutical Ingredients Market, Type of Synthesis

7.1.  Active Pharmaceutical Ingredients Market, Type of Synthesis Type, 2020-2030

7.1.1.    Biotech

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Synthetic

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer

8.1.  Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2020-2030

8.1.1.    Captive APIs

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Merchant APIs

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Active Pharmaceutical Ingredients Market, By Type

9.1.  Active Pharmaceutical Ingredients Market, By Type, 2020-2030

9.1.1.    Generic APIs

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Innovative APIs

9.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Active Pharmaceutical Ingredients Market, By Application

10.1.        Active Pharmaceutical Ingredients Market, By Application, 2020-2030

10.1.1.  Cardiovascular Diseases

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Oncology

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  CNS and Neurology

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Orthopedic

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Endocrinology

10.1.5.1.      Market Revenue and Forecast (2016-2030)

10.1.6.  Pulmonology

10.1.6.1.      Market Revenue and Forecast (2016-2030)

10.1.7.  Gastroenterology

10.1.7.1.      Market Revenue and Forecast (2016-2030)

10.1.8.  Nephrology

10.1.8.1.      Market Revenue and Forecast (2016-2030)

10.1.9.  Ophthalmology          

10.1.9.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Active Pharmaceutical Ingredients Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.1.2.  Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.1.3.  Market Revenue and Forecast, By Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By Application (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By Application (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By Application (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.2.2.  Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.2.3.  Market Revenue and Forecast, By Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By Application (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By Application (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By Application (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By Application (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By Application (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.3.2.  Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.3.3.  Market Revenue and Forecast, By Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By Application (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By Application (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By Application (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By Application (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By Application (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.4.2.  Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.4.3.  Market Revenue and Forecast, By Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By Application (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By Application (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By Application (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By Application (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By Application (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.5.2.  Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.5.3.  Market Revenue and Forecast, By Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By Application (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By Application (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, Type of Synthesis (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Type of Manufacturer (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By Application (2016-2030)

Chapter 12.  Company Profiles

12.1.              Merck & Co., Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              AbbVie, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Bristol-Myers Squibb Company

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Boehringer Ingelheim International GmbH

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Cipla, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Teva Pharmaceutical Industries Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Albemarle Corporation

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Viatris Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Aurobindo Pharma

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Sun Pharmaceutical Industries Ltd.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Dr. Reddy’s Laboratories Ltd.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37428
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:February 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers